Universe Pharmaceuticals INC (UPC): Price and Financial Metrics
UPC Price/Volume Stats
| Current price | $0.88 | 52-week high | $12.48 |
| Prev. close | $0.96 | 52-week low | $0.75 |
| Day low | $0.88 | Volume | 2,325 |
| Day high | $0.96 | Avg. volume | 36,517 |
| 50-day MA | $1.06 | Dividend yield | N/A |
| 200-day MA | $2.47 | Market Cap | 3.20M |
UPC Stock Price Chart Interactive Chart >
UPC Stock Summary
- UPC has a market capitalization of $5,075,010 -- more than approximately merely 2.53% of US stocks.
- UPC's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.33 -- higher than merely 4.46% of US-listed equities with positive expected earnings growth.
- UPC's price/sales ratio is 0.13; that's higher than the P/S ratio of just 3.01% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to UNIVERSE PHARMACEUTICALS INC are FALC, CLRO, DESP, SRTS, and GENC.
- Visit UPC's SEC page to see the company's official filings. To visit the company's web site, go to www.dzrzy.com.
UPC Valuation Summary
- In comparison to the median Healthcare stock, UPC's price/sales ratio is 97.73% lower, now standing at 0.1.
- Over the past 30 months, UPC's price/sales ratio has gone down 3.2.
Below are key valuation metrics over time for UPC.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| UPC | 2023-08-31 | 0.1 | 0.1 | -0.5 | 0.3 |
| UPC | 2023-08-30 | 0.1 | 0.1 | -0.6 | -0.4 |
| UPC | 2023-08-29 | 0.1 | 0.1 | -0.6 | -0.4 |
| UPC | 2023-08-28 | 0.1 | 0.1 | -0.6 | -0.4 |
| UPC | 2023-08-25 | 0.1 | 0.1 | -0.6 | -0.4 |
| UPC | 2023-08-24 | 0.1 | 0.1 | -0.6 | -0.4 |
Universe Pharmaceuticals INC (UPC) Company Bio
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief for common chronic health conditions in the elderly for the physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Jiangxi, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.
Latest UPC News From Around the Web
Below are the latest news stories about UNIVERSE PHARMACEUTICALS INC that investors may wish to consider to help them evaluate UPC as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWe're starting the week off right with a breakdown of the biggest pre-market stock movers worth knowing about on Monday morning! |
Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held SharesJiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 1, 2023, notifying the Company that it is not in compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) requirement set forth in the Nasdaq L |
Universe Pharmaceuticals INC Announces Share ConsolidationJiangxi, China, July 27, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of six (6) ordinary shares with par value of $0.003125 per share each in the Company’s issued and unissued share capital into one (1) ordinary share with par value of US$0.01875 (the “Share Consolidation”). As a result of the Share Conso |
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyJi’an, Jiangxi, China, March 07, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on March 2, 2023, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq Lis |
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19Ji’an, Jiangxi, China, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that six varieties of the Company’s products were included in the First Edition of Catalogue of Medicine for Patients Infected with COVID-19 (the “Catalogue”), which was published by Beijing Health Commission on December 12, 2022. The included products are Banlangen Granules, Strong Loquat Extract, Pediatric Parac |
UPC Price Returns
| 1-mo | -16.98% |
| 3-mo | -37.14% |
| 6-mo | -76.34% |
| 1-year | -91.67% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -89.89% |
| 2022 | -11.31% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...